EFFECTS OF GABEXATE MESILATE (FOY), A NEW SYNTHETIC SERINE PROTEASE INHIBITOR, ON BLOOD-COAGULATION IN PATIENTS WITH DIC

被引：0
|
作者：
PALARETI, G
MACCAFERRI, M
POGGI, M
PETRINI, F
COCCHERI, S
HAVERKATE, F
MONTANARI, F
CORTICELLI, AS
机构：
[1] UNIV HOSP S ORSOLO,DEPT ANGIOL & BLOOD COAGULAT,BULOGNA,ITALY
[2] UNIV HOSP S ORSOLO,DEPT INTENS CARE,BOLOGNA,ITALY
[3] GAUBIUS INST,LEIDEN,NETHERLANDS
来源：
THROMBOSIS AND HAEMOSTASIS | 1987年 / 58卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：420 / 420
页数：1
相关论文
共 50 条
  • [41] SENSITIVE DETECTION OF THE ACTIVATION STATE OF BLOOD-COAGULATION IN PORCINE DIC MODELS BY A NEW FIBRIN IMMUNOASSAY
    SPANNAGL, M
    TRAUNER, A
    BIRG, A
    FRANK, G
    HOFFMANN, H
    SIEBECK, M
    LILL, H
    BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (01) : 103 - 106
  • [42] The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS)
    Mellgren, K
    Skogby, M
    Friberg, LG
    Tengborn, L
    Wadenvik, H
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (02) : 342 - 347
  • [43] EFFECTS OF SERINE-PROTEASE INHIBITOR FOY-305 AND HEPARIN ON THE GROWTH OF SQUAMOUS-CELL CARCINOMA
    OHKOSHI, M
    AKAGAWA, T
    NAKAJIMA, M
    ANTICANCER RESEARCH, 1993, 13 (04) : 963 - 966
  • [44] EFFECTS OF CEFOTAXIME ON BLOOD-COAGULATION IN PATIENTS WITH RENAL-INSUFFICIENCY
    FUJITA, Y
    INOUE, S
    YORIFUJI, R
    AZUMA, M
    NISHIOKA, M
    GOTO, T
    DRUGS, 1988, 35 : 196 - 198
  • [45] CLONING AND EXPRESSION IN ESCHERICHIA-COLI OF A SYNTHETIC DNA FOR HIRUDIN, THE BLOOD-COAGULATION INHIBITOR IN THE LEECH
    FORTKAMP, E
    RIEGER, M
    HEISTERBERGMOUTSES, G
    SCHWEITZER, S
    SOMMER, R
    DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1986, 5 (06): : 511 - 517
  • [46] EFFECTS OF THE CONVERTING ENZYME-INHIBITOR CAPTOPRIL ON BLOOD-COAGULATION AND FIBRINOLYSIS IN MAN
    SCHRADER, J
    KOSTERING, H
    GRONE, HJ
    KIRCHERTZ, EJ
    SCHELER, F
    KLINISCHE WOCHENSCHRIFT, 1982, 60 (13): : 687 - 690
  • [47] The Serine Protease Inhibitor Camostat Mesilate Attenuates the Progression of Chronic Kidney Disease through its Antioxidant Effects
    Ueda, Miki
    Uchimura, Kohei
    Narita, Yuki
    Miyasato, Yoshikazu
    Mizumoto, Teruhiko
    Morinaga, Jun
    Hayata, Manabu
    Kakizoe, Yutaka
    Adachi, Masataka
    Miyoshi, Taku
    Shiraishi, Naoki
    Kadowaki, Daisuke
    Sakai, Yoshiki
    Mukoyama, Masashi
    Kitamura, Kenichiro
    NEPHRON, 2015, 129 (03) : 223 - 232
  • [48] MECHANISM-BASED ISOCOUMARIN INHIBITORS FOR TRYPSIN AND BLOOD-COAGULATION SERINE PROTEASES - NEW ANTICOAGULANTS
    KAM, CM
    FUJIKAWA, K
    POWERS, JC
    BIOCHEMISTRY, 1988, 27 (07) : 2547 - 2557
  • [49] Effects of novel synthetic serine protease inhibitors on postoperative blood loss, coagulation parameters, and vascular relaxation after cardiac surgery
    Szabo, Gabor
    Veres, Gabor
    Radovits, Tamas
    Haider, Humaira
    Krieger, Nelli
    Baehrle, Susanne
    Miesel-Groeschel, Christiane
    Niklisch, Silke
    Karck, Matthias
    van de Locht, Andreas
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 139 (01): : 181 - 188
  • [50] Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor
    Iwadou, H
    Morimoto, Y
    Iwagaki, H
    Sinoura, S
    Chouda, Y
    Kodama, M
    Yoshioka, T
    Saito, S
    Yagi, T
    Tanaka, N
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2002, 30 (02) : 99 - 108
12345